Common Title08-2070
Official Title Antiretroviral Activity and Tolerability of Once Daily Etravirine in Treatment-Naïve Adults With HIV-1 Infection
Phase Phase II
ClinicalTrials.gov NCT00959894
Categories Treatment-Naive
Funding
IndustryJanssen
References
- Floris-Moore MA, Mollan K, Wilkin AM, et al. Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results. Antivir Ther. 2016;21:55-64.